Sign inJoin waitlistJoin the waitlist

Lawrence Eichenfield

Chief of the Pediatric and Adolescent Dermatology Division and Co-Director, Vascular Lesion and Birthmark Center · University of California (San Diego) Medical Center

Credentials: · · · · ·

History

Vascular Lesion and Birthmark Center Division · University of California (San Diego) Medical Center
Present
University of California (San Diego) Medical Center
Present

University of Pennsylvania
1988–1989
Children's Hospital of Philadelphia
1985–1988
Preliminary or Transitional Year
1984–1985
Icahn School of Medicine at Mount Sinai
1980–1984

Research

Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
Journal of Allergy and Clinical Immunology · 2010 · 1,058 citations
Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel
Journal of Allergy and Clinical Immunology · 2010 · 1,030 citations
Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies
Journal of the American Academy of Dermatology · 2014 · First of 23 authors · 934 citations

Amy Paller
102 papers
Eric Simpson
67 papers
Jonathan Silverberg
50 papers
Adelaide Hebert
38 papers
Sheila Friedlander
36 papers
LG
Linda Stein Gold
32 papers
Elaine Siegfried
25 papers
Lisa Beck
25 papers
Emma Guttman
24 papers
MB
Mark Boguniewicz
24 papers
Moise Levy
24 papers
RS
Robert Sidbury
24 papers

Clinical trials

Cantharidin Application in Molluscum Patients-1
Principal investigator · Completed · Phase 3
Verrica Pharmaceuticals Inc.
2018
Cantharidin Application in Molluscum Patients
Principal investigator · Completed · Phase 3
Verrica Pharmaceuticals Inc.
2018
BM Collection From NICU Infants for Composition
Principal investigator · Completed
Kimberly-Clark Corporation
2015–2017
An International, Multi-centre, Prospective, Non-controlled, Open, Single-group, 8-week Trial in Adolescent Subjects
Principal investigator · Completed · Phase 2
LEO Pharma
2014–2018